These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 10961935)

  • 1. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminopeptidase A inhibitors as potential central antihypertensive agents.
    Reaux A; Fournie-Zaluski MC; David C; Zini S; Roques BP; Corvol P; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13415-20. PubMed ID: 10557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion].
    Llorens-Cortes C
    C R Seances Soc Biol Fil; 1998; 192(4):607-18. PubMed ID: 9842467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III.
    Réaux A; de Mota N; Zini S; Cadel S; Fournié-Zaluski MC; Roques BP; Corvol P; Llorens-Cortès C
    Neuroendocrinology; 1999 May; 69(5):370-6. PubMed ID: 10343178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.
    Fournie-Zaluski MC; Fassot C; Valentin B; Djordjijevic D; Reaux-Le Goazigo A; Corvol P; Roques BP; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7775-80. PubMed ID: 15136730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the brain renin-angiotensin system in hypertension: implications for new treatment.
    Marc Y; Llorens-Cortes C
    Prog Neurobiol; 2011 Oct; 95(2):89-103. PubMed ID: 21763394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors.
    Gao J; Marc Y; Iturrioz X; Leroux V; Balavoine F; Llorens-Cortes C
    Clin Sci (Lond); 2014 Aug; 127(3):135-48. PubMed ID: 24697296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of brain angiotensins II and III in thirst and sodium appetite.
    Wilson WL; Roques BP; Llorens-Cortes C; Speth RC; Harding JW; Wright JW
    Brain Res; 2005 Oct; 1060(1-2):108-17. PubMed ID: 16182260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
    Zini S; Fournie-Zaluski MC; Chauvel E; Roques BP; Corvol P; Llorens-Cortes C
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11968-73. PubMed ID: 8876246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminopeptidase A, generating one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, plays a key role in central control of blood pressure.
    Rozenfeld R; Reaux A; Iturrioz X; Fassot C; Fournie-Zaluski MC; David C; Maigret B; Roques BP; Corvol P; Llorens-Cortes C
    Proc West Pharmacol Soc; 2003; 46():39-44. PubMed ID: 14699881
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of dietary sodium on the blood pressure and renal sympathetic nerve activity responses to intracerebroventricular angiotensin II and angiotensin III in anaesthetized rats.
    Houghton BL; Huang C; Johns EJ
    Exp Physiol; 2010 Feb; 95(2):282-95. PubMed ID: 19880539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of angiotensin II conversion to angiotensin III increases water but not alcohol consumption in aminopeptidase A-deficient mice.
    Faber F; Gembardt F; Sun X; Mizutani S; Siems WE; Walther T
    Regul Pept; 2006 Sep; 136(1-3):130-7. PubMed ID: 16889841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system.
    Gammelgaard I; Wamberg S; Bie P
    Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain aminopeptidases and hypertension.
    Banegas I; Prieto I; Vives F; Alba F; de Gasparo M; Segarra AB; Hermoso F; Durán R; Ramírez M
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):129-34. PubMed ID: 17094048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei.
    de Mota N; Iturrioz X; Claperon C; Bodineau L; Fassot C; Roques BP; Palkovits M; Llorens-Cortes C
    J Neurochem; 2008 Jul; 106(1):416-28. PubMed ID: 18410507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer in vitro.
    Ławnicka H; Potocka AM; Juzala A; Fournie-Zaluski MC; Pawlikowski M
    Med Sci Monit; 2004 Nov; 10(11):BR410-3. PubMed ID: 15507845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminopeptidase A inhibitors as centrally acting antihypertensive agents.
    Bodineau L; Frugière A; Marc Y; Claperon C; Llorens-Cortes C
    Heart Fail Rev; 2008 Sep; 13(3):311-9. PubMed ID: 18175217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system-regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl-nitrosourea.
    Carrera MP; Ramírez-Expósito MJ; Valenzuela MT; Dueñas B; García MJ; Mayas MD; Martínez-Martos JM
    Cancer Invest; 2006 Mar; 24(2):149-53. PubMed ID: 16537183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.